[Image courtesy of iStock Photo]
Pharma and biotech companies looking to perform clinical trials in Eastern Asia and Central Asia may want to consider alternatives as the Russia–Ukraine War continues. Georgia and Kazakhstan, for instance, could be possible new venues for life science companies looking to conduct clinical trials. Russia and Ukraine both had strong clinical trial growthBefore the war’s disruption, Russia and Ukraine emerged as popular clinical trial sites. But the ongoing war in Ukraine has led to significant sanctions against Russia and logistical troubles. “It has had a great impact on clinical trials,” said Andrey Tarakanov, CEO of the clinical trial logistics firm COREX Logistics (Dublin, Ireland). In addition to its headquarters, COREX has locations in Kazakhstan, Georgia, Ukraine, Armenia, Russia and Belarus.
The number of clinical trials in Russia has skyrockete…